Watchlist Price Alert

Orchestra BioMed Inc. (OBIO)

NASDAQ: OBIO · Real-Time Price · USD

2.84

-0.10 (-3.40%)

At close: May 14, 2025, 3:59 PM

2.70

-5.00%

After-hours: May 14, 2025, 07:43 PM EDT

-3.40% (1D)

Bid	2.52
Market Cap	108.88M
Revenue (ttm)	2.89M
Net Income (ttm)	-66.32M
EPS (ttm)	-1.66
PE Ratio (ttm)	-1.71
Forward PE	-1.71
Analyst	Buy

Ask	3.32
Volume	204,505
Avg. Volume (20D)	367,483
Open	2.95
Previous Close	2.94
Day's Range	2.81 - 2.94
52-Week Range	2.37 - 8.87
Beta	0.66

About OBIO

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol OBIO

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for OBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Orchestra BioMed has released their quartely earnings on May 12, 2025:

Revenue of $868K exceeds estimates by $317.2K, with 40.00% YoY growth.

EPS of -0.49 misses estimates by -0.01, with -28.95% YoY decline.

Why Price Moved

2 days ago New

+10.94%

Orchestra BioMed shares are trading higher after t... Unlock content with Pro Subscription

3 weeks ago

+0.7%

Orchestra BioMed shares are trading higher after the company announced it secured FDA Breakthrough Device Designation for AVIM therapy.

News

3 days ago · zacks.com

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Tops Revenue Estimates

Orchestra BioMed Holdings, Inc. (OBIO) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to loss of $0.38 per share a year ago.

1 week ago · zacks.com

Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Orchestra BioMed Holdings, Inc. (OBIO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago · zacks.com

Orchestra BioMed Holdings, Inc. (OBIO) Reports Q4 Loss, Lags Revenue Estimates

Orchestra BioMed Holdings, Inc. (OBIO) came out with a quarterly loss of $0.43 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.37 per share a year ago.